CMS Extension And Leadership Shakeup Give Elevance Health Time To Rebuild Returns [Yahoo! Finance]
Elevance Health, Inc. (ELV)
Company Research
Source: Yahoo! Finance
Elevance Health (NYSE:ELV) received a last minute extension from the Centers for Medicare & Medicaid Services to correct risk adjustment data reporting issues tied to its Medicare Advantage plans. The CMS decision temporarily removes the threat of immediate sanctions that could have restricted new enrollments and affected member access. At the same time, Elevance announced leadership changes across its Health Benefits and Carelon units, aimed at sharpening execution in its services operations. For investors watching Elevance Health at a share price of $298.5, the CMS reprieve intersects with a weak recent track record for returns. NYSE:ELV shows a 15.7% decline year to date and a 29.0% decline over the past year, with longer periods such as 3 year and 5 year also reflecting double digit declines. Against that backdrop, avoiding immediate Medicare Advantage sanctions helps reduce an additional source of operational pressure. The management reshuffle at Health Benefits and Care
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (ELV) had its price target lowered by Robert W. Baird from $340.00 to $317.00. They now have a "neutral" rating on the stock.MarketBeat
- ELV SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsGlobeNewswire
- Elevance Health (ELV) had its price target lowered by Truist Financial Corporation from $390.00 to $375.00. They now have a "buy" rating on the stock.MarketBeat
- Elevance Health (ELV) is now covered by Evercore Inc. They set an "in-line" rating and a $345.00 price target on the stock.MarketBeat
- BofA Updates Managed Care Outlook, Raises Elevance Health (ELV) Price Target [Yahoo! Finance]Yahoo! Finance
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 4/7/26 - Form PX14A6G
- 3/27/26 - Form DEF
- 3/27/26 - Form DEFA14A
- ELV's page on the SEC website